Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Liao, H. Y.
  • Wang, S. C.
  • Ko, Y. A.
  • Lin, K. I.
  • Ma, C.
  • Cheng, T. J. R.
  • Wong, Chi-Huey

publication date

  • July 2020

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

subject areas

  • Animals
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antibody-Dependent Cell Cytotoxicity
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Cross Protection
  • Disease Models, Animal
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Humans
  • Influenza Vaccines
  • Influenza, Human
  • Mice
  • Models, Molecular
  • Neutralization Tests
  • Orthomyxoviridae
  • Recombinant Fusion Proteins
  • Structure-Activity Relationship
  • Vaccination
scroll to property group menus

Identity

PubMed Central ID

  • PMC7395492

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.2004783117

PubMed ID

  • 32669430
scroll to property group menus

Additional Document Info

start page

  • 17757

end page

  • 17763

volume

  • 117

issue

  • 30

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support